1994
DOI: 10.1111/j.1476-5381.1994.tb17172.x
|View full text |Cite
|
Sign up to set email alerts
|

Display of the characteristics of endothelium‐derived hyperpolarizing factor by a cytochrome P450‐derived arachidonic acid metabolite in the coronary microcirculation

Abstract: 1 In addition to nitric oxide (NO) and prostacyclin (PGI2) an endothelium-derived factor, which hyperpolarizes vascular smooth muscle cells via activation of K+ channels, contributes to the dilator effect of bradykinin in different vascular beds. Since this so-called endothelium-derived hyperpolarizing factor (EDHF) also seems to play an important role in the coronary circulation, we investigated its nature and mechanism of action in the rat isolated perfused heart (Langendorff preparation). 2 Bolus injections… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
109
1

Year Published

1996
1996
2006
2006

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 176 publications
(118 citation statements)
references
References 20 publications
8
109
1
Order By: Relevance
“…Epoxyeicosatrienoic acids formed from arachidonic acid by the action of cytochrome P-450 monooxygenase are candidates for the endothelium-derived hyperpolarizing factor (EDHF) (Bauersachs et al, 1994;Campbell et al, 1996;Chen and Cheung, 1996). Thus we tested two cytochrome P-450 inhibitors (clotrimazole and SKF 525A), and ETYA which inhibits arachidonic acid metabolism via cyclooxygenase, lipoxygenase and cytochrome P-450 monooxygenase (Pinto et al, 1987;Capdevila et al, 1988).…”
Section: Discussionmentioning
confidence: 99%
“…Epoxyeicosatrienoic acids formed from arachidonic acid by the action of cytochrome P-450 monooxygenase are candidates for the endothelium-derived hyperpolarizing factor (EDHF) (Bauersachs et al, 1994;Campbell et al, 1996;Chen and Cheung, 1996). Thus we tested two cytochrome P-450 inhibitors (clotrimazole and SKF 525A), and ETYA which inhibits arachidonic acid metabolism via cyclooxygenase, lipoxygenase and cytochrome P-450 monooxygenase (Pinto et al, 1987;Capdevila et al, 1988).…”
Section: Discussionmentioning
confidence: 99%
“…The aim of the present study was to determine whether a crosstalk occurs between CB1 receptor activation or inactivation and endothelial autacoid production. To this end we studied the e ects of CB1 receptor agonists (HU 210, D 9 -THC and anandamide) and the selective antagonist/inverse agonist SR 141716A (Bouaboula et al, 1997) on the vascular tone of three di erent arteries all of which synthesize both nitric oxide (NO) and an EDHF which is characterized as a CYP-dependent metabolite of arachidonic acid (Bauersachs et al, 1994;Popp et al, 1996;.…”
Section: Introductionmentioning
confidence: 99%
“…The relative contribution of these factors may vary under di erent experimental conditions as all three may cause hyperpolarization of vascular smooth muscle (Parkington et al, 1993), release of EDHF is attenuated by NO (Bauersachs et al, 1996), and NO may stimulate the synthesis of prostanoids (Salvemini et al, 1993). The chemical nature of EDHF is unknown, candidate mediators including the endocannabinoid, anandamide (Randall & Kendall, 1998), and epoxyeicosatrienoic acids (EETs) which are cytochrome P 450 mono-oxygenase derived metabolites of arachidonic acid (Bauersachs et al, 1994).…”
mentioning
confidence: 99%